Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local-Tax Trial: Local Intracoronary Administration of Paclitaxel After Stent Implantation for Prevention of Restenosis in Comparison With Stent Implantation Alone and With Implantation of a Paclitaxel-Eluting Stent

NCT00396929 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00396929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local-Tax Trial: Local Intracoronary Administration of Paclitaxel After Stent Implantation for Prevention of Restenosis in Comparison With Stent Implantation Alone and With Implantation of a Paclitaxel-Eluting Stent
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2005
Completion date
July 31, 2007
Enrollment
204 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia, stable or unstable angina pectoris